Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: The case of synapsins

Frontiers in Pediatrics

Volumn 2, Issue SEP, 2014, Pages

  Giovedí, Silvia ^a   Corradi, Anna ^a   Fassio, Anna ^a,b   Benfenati, Fabio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Autism; Human mutations; Knockout mice; Social behavior; Synaptic transmission; Synaptic vesicles; Synaptopathies

Indexed keywords

EID: 84916621441     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2014.00094     Document Type: Review

References (75)

1. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 9:341-55. doi: 10.1038/nrg2346
2. Levitt P, Campbell DB. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest (2009) 119:747-54. doi:10.1172/JCI37934
3. Persico AM, Napolioni V. Autism genetics. Behav Brain Res (2013) 251:95-112. doi:10.1016/j.bbr.2013.06.012
4. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet (2014) 294:677-94. doi:10.1016/j.ajhg.2014.03.018
5. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 34:27-9. doi:10.1038/ng1136
6. Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 302:826-30. doi:10.1126/science.1089071
7. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 455:903-11. doi:10.1038/nature07456
8. Bentacur C, Sakurai T, Buxbaum JD. The emerging role of synaptic cell adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci (2009) 32:402-12. doi:10.1016/j.tins.2009.04.003
9. Redies C, Hertel N, Hübner CA. Cadherins and neuropsychiatric disorders. Brain Res (2012) 1470:130-44. doi:10.1016/j.brainres.2012.06.020
10. Jiang YH, Ehlers MD. Modeling autism by SHANK gene mutations in mice. Neuron (2013) 78:8-27. doi:10.1016/j.neuron.2013.03.016
11. Shao Y, Cuccaro ML, Hauser ER, Raiford KL, Menold MM, Wolpert CM, et al. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet (2003) 72:539-48. doi:10.1086/367846
12. Li X, Zou H, Brown WT. Genes associated with autism spectrum disorder. Brain Res Bull (2012) 88:543-52. doi:10.1016/j.brainresbull.2012.05.017
13. Schmunk G, Gargus JJ. Channelopathy pathogenesis in autism spectrum disorders. Front Genet (2013) 4:222. doi:10.3389/fgene.2013.00222
14. Piton A, Michaud JL, Peng H, Aradhya S, Gauthier J, Mottron L, et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 17:3965-74. doi:10.1093/hmg/ddn300
15. Kumar RA, Sudi J, Babatz TD, Brune CW, Oswald D, Yen M, et al. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism. J Med Genet (2010) 47:81-90. doi:10.1136/jmg.2008.065821
16. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO, et al. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 69:898-901. doi:10.1016/j.biopsych.2010.11.015
17. Berryer MH, Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, et al. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat (2013) 34:385-94. doi:10.1002/humu.22248
18. Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol (2012) 4:a009886. doi:10.1101/cshperspect.a009886
19. Delorne R, Ely E, Toro R, Leboyer M, Gillberg C, Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat Med (2013) 6:685-94. doi:10.1038/nm.3193
20. Banerjee S, Riordan M, Bhat MA. Genetic aspects of autism spectrum disorders: insight from animal models. Front Cell Neurosci (2014) 8:58. doi:10.3389/fncel.2014.00058
21. Kleijer KT, Schmeisser MJ, Krueger DD, Boeckers TM, Scheiffele P, Bourgeron T, et al. Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl) (2014) 231:1037-42. doi:10.1007/s00213-013-3403-3
22. Zoghbi HY. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 468:263-9. doi:10.1038/nature09582
23. Ramamoorthi K, Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol Med (2011) 17:452-62. doi:10.1016/j.molmed.2011.03.003
24. Pizzarelli R, Cherubini E. Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast (2011) 2011:297153. doi:10.1155/2011/297153
25. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev (2012) 36:2044-55. doi:10.1016/j.neubiorev.2012.07.005
26. Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 468:263-9. doi:10.1038/nature09582
27. Selby L, Zhang C, Sun QQ. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett (2007) 412:227-32. doi:10.1016/j.neulet.2006.11.062
28. DeLorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2008) 187:207-20. doi:10.1016/j.bbr.2007.09.009
29. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain (1998) 121:889-905. doi:10.1093/brain/121.5.889
30. Carboni G, Tueting P, Tremolizzo L, Sugaya I, Davis J, Costa E, et al. Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation. Neuropharmacology (2004) 46:1070-81. doi:10.1016/j.neuropharm.2004.02.001
31. Gitler D, Takagishi Y, Feng J, Ren Y, Rodriguiz RM, Wetsel WC, et al. Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci (2004) 24:11368-80. doi:10.1523/JNEUROSCI.3795-04.2004
32. Baldelli P, Fassio A, Valtorta F, Benfenati F. Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci (2007) 27:13520-31. doi:10.1523/JNEUROSCI.3151-07.2007
33. Chiappalone M, Casagrande S, Tedesco M, Valtorta F, Baldelli P, Martinoia S, et al. Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb Cortex (2008) 19:1422-39. doi:10.1093/cercor/bhn182
34. Farisello P, Boido D, Nieus T, Medrihan L, Cesca F, Valtorta F, et al. Synaptic and extrasynaptic origin of the excitation/inhibition imbalance in the hippocampus of synapsin I/II/III knockout mice. Cereb Cortex (2013) 23:581-93. doi:10.1093/cercor/bhs041
35. Medrihan L, Cesca F, Raimondi A, Lignani G, Baldelli P, Benfenati F. Synapsin II desynchronizes neurotransmitter release at inhibitory synapses by interacting with presynaptic calcium channels. Nat Commun (2013) 4:1512. doi:10.1038/ncomms2515
36. Cesca F, Baldelli P, Valtorta F, Benfenati F. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol (2010) 91:313-48. doi:10.1016/j.pneurobio.2010.04.006
37. Fornasiero EF, Bonanomi D, Benfenati F, Valtorta F. The role of synapsins in neuronal development. Cell Mol Life Sci (2010) 67:1383-96. doi:10.1007/s00018-009-0227-8
38. Südhof TC, Czernik AJ, Kao H-T, Takei K, Johnston PA, Horiuchi A, et al. Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science (1989) 245:1474-80. doi:10.1126/science.2506642
39. Porton B, Kao H-T, Greengard P. Characterization of transcripts from the synapsin III gene locus. J Neurochem (1999) 73:2266-71. doi:10.1046/j.1471-4159.1999.0732266.x
40. Porton B, Wetsel WC, Kao H-T. Synapsin III: role in neuronal plasticity and disease. Semin Cell Dev Biol (2011) 22:416-24. doi:10.1016/j.semcdb.2011.07.007
41. Bogen IL, Jensen V, Hvalby O, Walaas SI. Synapsin-dependent development of glutamatergic synaptic vesicles and presynaptic plasticity in postnatal mouse brain. Neuroscience (2009) 158:231-41. doi:10.1016/j.neuroscience.2008.05.055
42. Benfenati F, Valtorta F, Rossi MC, Onofri F, Sihra T, Greengard P. Interactions of synapsin I with phospholipids: possible role in synaptic vesicle clustering and in the maintenance of bilayer structures. J Cell Biol (1993) 123:1845-55. doi:10.1083/jcb.123.6.1845
43. Hosaka M, Südhof TC. Homo-and heterodimerization of synapsins. J Biol Chem (1999) 274:16747-53. doi:10.1074/jbc.274.24.16747
44. Onofri F, Messa M, Matafora V, Bonanno G, Corradi A, Bachi A, et al. Synapsin phosphorylation by SRC tyrosine kinase enhances SRC activity in synaptic vesicles. J Biol Chem (2007) 282:15754-67. doi:10.1074/jbc.M701051200
45. Esser L, Wang CR, Hosaka M, Smagula CS, Südhof TC, Deisenhofer J. Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J (1998) 17:977-84. doi:10.1093/emboj/17.4.977
46. Onofri F, Giovedí S, Kao H-T, Valtorta F, Bongiorno Borbone L, De Camilli P, et al. Specificity of the binding of synapsin I to SRC homology 3 domains. J Biol Chem (2000) 275:29857-67. doi:10.1074/jbc.M006018200
47. Giovedí S, Darchen F, Valtorta F, Greengard P, Benfenati F. Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction. J Biol Chem (2004) 279:43769-79. doi:10.1074/jbc.M404168200
48. Benfenati F, Valtorta F, Rubenstein JL, Gorelick FS, Greengard P, Czernik AJ. Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature (1992) 359:417-20. doi:10.1038/359417a0
49. Verstegen AM, Tagliatti E, Lignani G, Marte A, Stolero T, Atias M, et al. Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses. J Neurosci (2014) 34:7266-80. doi:10.1523/JNEUROSCI.3973-13.2014
50. Hilfiker S, Schweizer FE, Kao H-T, Czernik AJ, Greengard P, Augustine GJ. Two sites of action for synapsin domain E in regulating neurotransmitter release. Nat Neurosci (1998) 1:29-35. doi:10.1038/1147
51. Gitler D, Xu Y, Kao H-T, Lin D, Lim S, Feng J, et al. Molecular determinants of synapsin targeting to presynaptic terminals. J Neurosci (2004) 224:3711-20. doi:10.1523/JNEUROSCI.5225-03.2004
52. Fassio A, Merlo D, Mapelli J, Menegon A, Corradi A, Mete M, et al. The synapsin domain E accelerates the exoendocytotic cycle of synaptic vesicles in cerebellar Purkinje cells. J Cell Sci (2006) 119:4257-68. doi:10.1242/jcs.03194
53. Monaldi I, Vassalli M, Bachi A, Giovedí S, Millo E, Valtorta F, et al. The highly conserved synapsin domain E mediates synapsin dimerization and phospholipid vesicle clustering. Biochem J (2010) 426:55-64. doi:10.1042/BJ20090762
54. Chin LS, Li L, Ferreira A, Kosik KS, Greengard P. Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc Natl Acad Sci U S A (1995) 92:9230-4. doi:10.1073/pnas.92.20.9230
55. Ferreira A, Kao H-T, Feng J, Rapoport M, Greengard P. Synapsin III: developmental expression, subcellular localization, and role in axon formation. J Neurosci (2000) 20:3736-44
56. Li L, Chin LS, Shupliakov O, Brodin L, Sihra TS, Hvalby O, et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc Natl Acad Sci U S A (1995) 92:9235-9. doi:10.1073/pnas.92.20.9235
57. Takei Y, Harada A, Takeda S, Kobayashi K, Terada S, Noda T, et al. Synapsin I deficiency results in the structural change in the presynaptic terminals in the murine nervous system. J Cell Biol (1995) 131:1789-800. doi:10.1083/jcb.131.6.1789
58. Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 375:488-93. doi:10.1038/375488a0
59. Cambiaghi M, Cursi M, Monzani E, Benfenati F, Comi G, Minicucci F, et al. Temporal evolution of neurophysiological and behavioral features of synapsin I/II/III triple knock-out mice. Epilepsy Res (2013) 103:153-60. doi:10.1016/j.eplepsyres.2012.07.012
60. Etholm L, Bahonjic E, Heggelund P. Sensitive and critical periods in the development of handling induced seizures in mice lacking synapsins: differences between synapsin I and synapsin II knockouts. Exp Neurol (2013) 247:59-65. doi:10.1016/j.expneurol.2013.03.025
61. Fassio A, Raimondi A, Lignani G, Benfenati F, Baldelli P. Synapsins: from synapse to network hyperexcitability and epilepsy. Semin Cell Dev Biol (2011) 22:408-15. doi:10.1016/j.semcdb.2011.07.005
62. Feng J, Chi P, Blanpied TA, Xu Y, Magarinos AM, Ferreira A, et al. Regulation of neurotransmitter release by synapsin III. J Neurosci (2002) 22:4372-80
63. Corradi A, Zanardi A, Giacomini C, Onofri F, Valtorta F, Zoli M, et al. Synapsin-I-and synapsin-II-null mice display an increased age-dependent cognitive impairment. J Cell Sci (2008) 121:3042-51. doi:10.1242/jcs.035063
64. Porton B, Rodriguiz RM, Phillips LE, Gilbert JW IV, Feng J, Greengard P, et al. Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear. Genes Brain Behav (2010) 9:257-68. doi:10.1111/j.1601-183X.2009.00555.x
65. Greco B, Managò F, Tucci V, Kao H-T, Valtorta F, Benfenati F. Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res (2013) 251:65-74. doi:10.1016/j.bbr.2012.12.015
66. Garcia CC, Blair HJ, Seager M, Coulthard A, Tennant S, Buddles M, et al. Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet (2004) 41:183-6. doi:10.1136/jmg.2003.013680
67. Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet (2011) 20:2297-307. doi:10.1093/hmg/ddr122
68. Corradi A, Fadda M, Piton A, Patry L, Marte A, Rossi P, et al. SYN2 is an autism predisposing gene: loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth. Hum Mol Genet (2014) 23:90-103. doi:10.1093/hmg/ddt401
69. Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, et al. Shank1 deletions in males with autism spectrum disorder. Am J Hum Genet (2012) 90:879-87. doi:10.1016/j.ajhg.2012.03.017
70. Giannandrea M, Guarnieri FC, Gehring NH, Monzani E, Benfenati F, Kulozik AE, et al. Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356X mutation in synapsin I. PLoS One (2013) 8:e67724. doi:10.1371/journal.pone.0067724
71. Lignani G, Raimondi A, Ferrea E, Rocchi A, Paonessa F, Cesca F, et al. Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity. Hum Mol Genet (2013) 22:2186-99. doi:10.1093/hmg/ddt071
72. Anderson GR, Galfin T, Xu W, Aoto J, Malenka RC, Sudhof TC. Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc Natl Acad Sci U S A (2012) 109:18120-5. doi:10.1073/pnas.1216398109
73. Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentini FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics (2011) 12:238-49. doi:10.2174/138920211795860107
74. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM, International Schizophrenia Consortium X, et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry (2012) 17:996-1006. doi:10.1038/mp.2011.117
75. Ruano D, Abecasis GR, Glaser B, Lips ES, Cornelisse LN, de Jong AP, et al. Functional gene group analysis reveals a role for synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet (2010) 12(86):113-25. doi:10.1016/j.ajhg.2009.12.006